Evaluation of T2 Magnetic Resonance (T2MR ® ) Technology for the Early Detection of ESKAPEc Pathogens in Septic Patients

Bloodstream infections (BSIs) and sepsis are a major cause of morbidity and mortality. Appropriate early antibiotic therapy is crucial for improving the survival of patients with sepsis and septic shock. T2 magnetic resonance (T2MR ) technology may enable fast and sensitive detection of ESKAPEc path...

Full description

Saved in:
Bibliographic Details
Published in:Antibiotics (Basel) Vol. 13; no. 9; p. 885
Main Authors: Bonura, Celestino, Graceffa, Domenico, Distefano, Salvatore, De Grazia, Simona, Guzman, Oscar, Bohn, Brian, Ippolito, Mariachiara, Campanella, Salvatore, Ancona, Angelica, Caputo, Marta, Mirasola, Pietro, Palmeri, Cesira, Raineri, Santi Maurizio, Giarratano, Antonino, Giammanco, Giovanni Maurizio, Cortegiani, Andrea
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 14-09-2024
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bloodstream infections (BSIs) and sepsis are a major cause of morbidity and mortality. Appropriate early antibiotic therapy is crucial for improving the survival of patients with sepsis and septic shock. T2 magnetic resonance (T2MR ) technology may enable fast and sensitive detection of ESKAPEc pathogens directly from whole-blood samples. We aimed to evaluate concordance between the T2Bacteria Panel and standard blood culture and its impact on antibiotic therapy decisions. We conducted a single-centre retrospective study on patients with sepsis-induced hypotension or septic shock admitted to general, post-operative/neurosurgical, and cardiothoracic Intensive Care Units who were tested with the T2Bacteria Panel from January 2021 to December 2022. Eighty-five consecutively admitted patients were included, for a total of 85 paired tests. A total of 48 ESKAPEc pathogens were identified by the T2Bacteria Panel. The concordance rate between the T2Bacteria Panel and blood cultures was 81% (69/85), with 20 concordant-positive and 49 concordant-negative cases. For the 25 microorganisms grown from accompanying blood cultures, blood pathogen coverage by the T2Bacteria Panel was 88%. In this cohort of severely ill septic patients, the T2Bacteria Panel was highly concordant and was able to detect more ESKAPEc pathogens, with a significantly shorter turn-around time compared to conventional blood cultures. The T2Bacteria Panel also significantly impacted decisions on antibiotic therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2079-6382
2079-6382
DOI:10.3390/antibiotics13090885